Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FLUNARIZINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 244 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Diener, HC; Limmroth, V
      Advances in pharmacological treatment of migraine

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Belforte, JE; Magarinos-Azcone, C; Armando, I; Buno, W; Pazo, JH
      Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum

      PARKINSONISM & RELATED DISORDERS
    3. Dubovsky, SL; Buzan, R; Thomas, M; Kassner, C; Cullum, CM
      Nicardipine improves the antidepressant action of ECT but does not improvecognition

      JOURNAL OF ECT
    4. Quartermain, D; DeSoria, VG; Kwan, A
      Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice

      NEUROBIOLOGY OF LEARNING AND MEMORY
    5. Pothmann, R; Luka-Krausgrill, U; Seemann, H; Naumann, E
      Treatment of headache in children. Recommendations of the pain therapy study group of the DGSS

      SCHMERZ
    6. Pledger, G
      Proof of efficacy trials: choosing the dose

      EPILEPSY RESEARCH
    7. Genc, H; Bagirici, F; Cakir, A; Demir, S; Tan, F
      Effects of flunarizine on cadmium-induced Purkinje cell loss in rats

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    8. Bagirici, F; Gokce, FM; Demir, S; Marangoz, C
      Calcium channel blocker flunarizine suppresses epileptiform activity induced by penicillin in rats

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    9. Sasaki, M; Sakuragawa, N; Osawa, M
      Long-term effect of flunarizine on patients with alternating hemiplegia ofchildhood in Japan

      BRAIN & DEVELOPMENT
    10. Diener, HC; Hartung, E; Chrubasik, J; Evers, S; Schoenen, J; Eikermann, A; Latta, G; Hauke, W
      A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study

      CEPHALALGIA
    11. Limmroth, V; Michel, MC
      The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    12. Horn, J; Limburg, M
      Calcium antagonists for ischemic stroke - A systematic review

      STROKE
    13. Ruiz-Nuno, A; Villarroya, M; Cano-Abad, M; Rosado, A; Balfagon, G; Lopez, MG; Garcia, AG
      Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Hu, LY; Ryder, TR; Rafferty, MF; Taylor, CP; Feng, MR; Kuo, BS; Lotarski, SM; Miljanich, GP; Millerman, E; Siebers, KM; Szoke, BG
      The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phenyl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia

      BIOORGANIC & MEDICINAL CHEMISTRY
    15. Grossmann, M; Schmidramsl, H
      An extract of Petasites hybridus is effective in the prophylaxis of migraine

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    16. Della Paschoa, OE; Hoogerkamp, A; Edelbroek, PM; Voskuyl, RA; Danhof, M
      Pharmacokinetic-pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model

      EPILEPSY RESEARCH
    17. Mikati, MA; Kramer, U; Zupanc, ML; Shanahan, RJ
      Alternating hemiplegia of childhood: Clinical manifestations and long-termoutcome

      PEDIATRIC NEUROLOGY
    18. Matsuo, H; Matsui, A; Nasu, R; Takanaga, H; Inoue, N; Hattori, F; Ohtani, W; Sawada, Y
      Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice

      PHARMACEUTICAL RESEARCH
    19. Khosla, P; Pandhi, P
      Anticonvulsant effect of nimodipine alone and in combination with diazepamand phenytoin in a mouse model of status epilepticus

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    20. Gorji, A; Scheller, D; Tegtmeier, F; Kohling, R; Straub, H; Speckmann, EJ
      NiCl2 and amiloride induce spreading depression in guinea pig hippocampal slices

      CEPHALALGIA
    21. El-Sabban, F; Reid, KH; Edmonds, HL
      Comparative effect of flunarizine in two animal models of stroke

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    22. Chung, YH; Shin, CM; Kim, MJ; Cha, CI
      Immunohistochemical study on the distribution of the type I and type II voltage-gated sodium channels in the gerbil cerebellum

      NEUROSCIENCE LETTERS
    23. Bursztyn, J; Mikaeloff, Y; Kaminska, A; Plouin, P; Soufflet, C; Dulac, O; Chaix, Y
      Alternating hemiplegia of childhoood and oculomotor anomalies

      JOURNAL FRANCAIS D OPHTALMOLOGIE
    24. Sone, K; Oguni, H; Katsumori, H; Funatsuka, M; Tanaka, T; Osawa, M
      Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood

      NEUROPEDIATRICS
    25. Nasu, R; Matsuo, H; Takanaga, H; Ohtani, H; Sawada, Y
      Quantitative prediction of catalepsy induced by amoxapine, cinnarizine andcyclophosphamide in mice

      BIOPHARMACEUTICS & DRUG DISPOSITION
    26. Matthew, CB; Sils, IV
      Flunarizine pretreatment attenuates hyperthermia-induced extravasation in rats

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    27. Toriu, N; Akaike, A; Yasuyoshi, H; Zhang, S; Kashii, S; Honda, Y; Shimazawa, M; Hara, H
      Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina

      EXPERIMENTAL EYE RESEARCH
    28. Fuh, MR; Hsieh, CJ
      Determination of flunarizine in rat brain by liquid chromatography-electrospray mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    29. Arieli, R; Shupak, A; Shachal, B; Shenedrey, A; Ertracht, O; Rashkovan, G
      Effect of the anti-motion-sickness medication cinnarizine on central nervous system oxygen toxicity

      UNDERSEA & HYPERBARIC MEDICINE
    30. Kaminski, R; Jasinski, M; Jagiello-Wojtowicz, E; Kleinrok, Z; Czuczwar, SJ
      Effect of amlodipine upon the protective activity of antiepileptic drugs against maximal electro shock-induced seizures in mice

      PHARMACOLOGICAL RESEARCH
    31. Annoura, H; Nakanishi, K; Uesugi, M; Fukunaga, A; Miyajima, A; Tamura-Horikawa, Y; Tamura, S
      A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    32. Baldassarre, JS; Pledger, GW
      Clinical trial design for new antiepileptic drugs: Determination of dose and titration schedules

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    33. Arbab, AS; Koizumi, K; Toyama, K; Arai, T; Araki, T
      Effects of ion channel modulators in the influx and efflux of Tc-99m-MIBI

      ANNALS OF NUCLEAR MEDICINE
    34. Bell, KR; Kraus, EE; Zasler, ND
      Medical management of posttraumatic headaches: Pharmacological and physical treatment

      JOURNAL OF HEAD TRAUMA REHABILITATION
    35. Uslu, B; Yilmaz, N; Erk, N; Ozkan, SA; Senturk, Z; Biryol, I
      The study of the voltammetric behaviour of flunarizine

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    36. Kelani, K; Bebawy, LI; Abdel-Fattah, L
      Determination of astemizole, terfenadine and flunarizine hydrochloride by ternary complex formation with eosin and lead(II)

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    37. Deleu, D; Hanssens, Y
      Guidelines for the prevention of migraine

      SAUDI MEDICAL JOURNAL
    38. Cupini, LM; Troisi, E; Placidi, F; Diomedi, M; Silvestrini, M; Argiro, G; Bernardi, G
      Does the antimigraine action of flunarizine involve the dopaminergic system? A clinical-neuroendocrinological study

      CEPHALALGIA
    39. Becker, WJ
      Evidence based migraine prophylactic drug therapy

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    40. Hara, H; Shimazawa, M; Sasaoka, M; Yamada, C; Iwakura, Y; Sakai, T; Maeda, Y; Yamaguchi, T; Sukamoto, T; Hashimoto, M
      Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    41. Lee, YS; Yoon, BW; Roh, JK
      Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischemia

      NEUROSCIENCE LETTERS
    42. Patro, IK; Chattopadhyay, M; Patro, N
      Flunarizine enhances functional recovery following sciatic nerve crush lesion in rats

      NEUROSCIENCE LETTERS
    43. Futuro-Neto, HA; Costa, PG; Amorim, SC; Saraiva, FP; Ribeiro, CAA; Pires, JGP
      Evidence of sex related differences in the effects of calcium channel blockers on neuroleptic-induced catalepsy in mice

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    44. Genc, O; Demir, S; Tasci, N; Kaptanoglu, B; Marangoz, C
      Effects of the calcium channel blocker flunarizine on spinal reflexes in cats

      MEDICAL SCIENCE RESEARCH
    45. Sukhotina, IA; Dravolina, OA; Medvedev, IO; Bespalov, AY
      Effects of calcium channel blockers on behaviors induced by the N-methyl-D-aspartate receptor antagonist, dizocilpine, in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    46. Fuh, MRS; Hsieh, CJ; Tai, YL
      Optimization for detection of flunarizine by high performance liquid chromatography/electrospray/mass spectrometry

      TALANTA
    47. Guan, HP; Ku, BS
      Neuroprotective effect of L-lysine monohydrochloride on acute iterative anoxia in rats with quantitative analysis of electrocorticogram

      LIFE SCIENCES
    48. Mitsuda, M; Nomoto, M; Iwata, S
      Effects of beta-blockers and nicardipine on oxotremorine-induced tremor incommon marmosets

      JAPANESE JOURNAL OF PHARMACOLOGY
    49. Bussone, G; Cerbo, R; Martucci, N; Micieli, G; Zanferrari, C; Grazzi, L; Fabbrini, G; Cavallini, A; Granella, F; Ambrosoli, L; Mailland, F; Poli, A; Manzoni, G
      alpha-dihydroergocryptine in the prophylaxis of migraine: A multicenter double-blind study versus flunarizine

      HEADACHE
    50. Schierle, GS; Brundin, P
      Excitotoxicity plays a role in the death of tyrosine hydroxylase-immunopositive nigral neurons cultured in serum-free medium

      EXPERIMENTAL NEUROLOGY
    51. Novalbos, J; Abad-Santos, F; Zapater, P; Cano-Abad, MF; Moradiellos, J; Sanchez-Garcia, P; Garcia, AG
      Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+

      EUROPEAN JOURNAL OF PHARMACOLOGY
    52. Weizman, R; Getslev, V; Pankova, IA; Schrieber, S; Pick, CG
      Pharmacological interaction of the calcium channel blockers verapamil and flunarizine with the opioid system

      BRAIN RESEARCH
    53. Serra, M; Dazzi, L; Caddeo, M; Floris, C; Biggio, G
      Reversal by flunarizine of the decrease in hippocampal acetylcholine release in pentylenetetrazole-kindled rats

      BIOCHEMICAL PHARMACOLOGY
    54. Torregrosa, G; Barbera, MD; Orti, M; Centeno, JM; Salom, JB; Alborch, E
      Cerebrovascular effects of dotarizine, a piperazine derivative, in the goat - An in vivo and in vitro complementary study

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    55. COX B; DENYER JC
      N-TYPE CALCIUM-CHANNEL BLOCKERS IN PAIN AND STROKE

      Expert opinion on therapeutic patents
    56. BELFIORE G; DIMAIO L; NAPOLITANO G; CELLA S; FILLA A; DEMICHELE G; CAMPANELLA G
      LONG-TERM EFFECT OF A SINGLE-DOSE OF FLUNARIZINE IN HUNTINGTONS-DISEASE

      European journal of neurology
    57. HAMALAINEN ML
      MIGRAINE IN CHILDREN - GUIDELINES FOR TREATMENT

      CNS drugs
    58. TRETTER L; ADAMVIZI V
      THE NEUROPROTECTIVE DRUG VINPOCETINE PREVENTS VERATRIDINE-INDUCED [NA+](I) AND [CA2(+)](I) RISE IN SYNAPTOSOMES

      NeuroReport
    59. DOERR TD; DZIADZIOLA JK; KOMJATHY DA; BURGIO DL; QUIRK WS
      THE EFFECTS OF FLUNARIZINE AND PENTOXIFYLLINE ON VESTIBULAR BLOOD-FLOW IN THE GUINEA-PIG

      European archives of oto-rhino-laryngology
    60. MARTIMASSO JF; POZA JJ
      CINNARIZINE-INDUCED PARKINSONISM - 10 YEARS LATER

      Movement disorders
    61. OVSIEW F; MEADOR KJ; SETHI K
      VERAPAMIL FOR SEVERE HYPERKINETIC MOVEMENT-DISORDERS

      Movement disorders
    62. RHO JM; CHUGANI HT
      ALTERNATING HEMIPLEGIA OF CHILDHOOD - INSIGHTS INTO ITS PATHOPHYSIOLOGY

      Journal of child neurology
    63. MORALESASIN F; MAURI JA; INIGUEZ C; ESPADA F; MOSTACERO E
      THE HYPNIC HEADACHE SYNDROME - REPORT OF 3 NEW CASES

      Cephalalgia
    64. GRANELLA F; CAVALLINI A; SANDRINI G; MANZONI GC; NAPPI G
      LONG-TERM OUTCOME OF MIGRAINE

      Cephalalgia
    65. Arnold, G; Reuter, U; Kinze, S; Wolf, T; Einhaupl, KM
      Migraine with aura shows gadolinium enhancement which is reversed following prophylactic treatment

      CEPHALALGIA
    66. Arnar, DO; Cai, JJ; Lee, HC; Martins, JB
      Electrophysiologic effects of civamide (Zucapsaicin) on canine cardiac tissue in vivo and in vitro

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    67. HARAGUCHI K; ITO K; KOTAKI H; SAWADA Y; IGA T
      CATALEPSY INDUCED BY CALCIUM-CHANNEL BLOCKERS IN MICE

      Biopharmaceutics & drug disposition
    68. HIGELIN F; ANNONI JM
      MEDICAL-TREATMENT OF MIGRAINE - FROM MECHANISMS OF ACTION TO CONTRAINDICATIONS

      Schweizerische medizinische Wochenschrift
    69. DELZOMPO M; CHERCHI A; PALMAS MA; PONTI M; BOCCHETTA A; GESSA GL; PICCARDI MP
      ASSOCIATION BETWEEN DOPAMINE-RECEPTOR GENES AND MIGRAINE WITHOUT AURAIN A SARDINIAN SAMPLE

      Neurology
    70. GASIOR M; SWIADER M; PRZYBYLKO M; BOROWICZ K; TURSKI WA; KLEINROK Z; CZUCZWAR SJ
      FELBAMATE DEMONSTRATES LOW PROPENSITY FOR INTERACTION WITH METHYLXANTHINES AND CA2+ CHANNEL MODULATORS AGAINST EXPERIMENTAL SEIZURES IN MICE

      European journal of pharmacology
    71. ELIMADI A; BOUILLOT L; SAPENA R; TILLEMENT JP; MORIN D
      DOSE-RELATED INVERSION OF CINNARIZINE AND FLUNARIZINE EFFECTS ON MITOCHONDRIAL PERMEABILITY TRANSITION

      European journal of pharmacology
    72. Ishibashi, H; Murai, Y; Akaike, N
      Effect of nilvadipine on the voltage-dependent Ca2+ channels in rat hippocampal CA1 pyramidal neurons

      BRAIN RESEARCH
    73. AKISU M; KULTURSAY N; COKER I; HUSEYINOV A
      PLATELET-ACTIVATING-FACTOR IS AN IMPORTANT MEDIATOR IN HYPOXIC-ISCHEMIC BRAIN INJURY IN THE NEWBORN RAT

      Biology of the neonate
    74. Ishibashi, H; Arima, J; Rhee, JS; Akaike, N
      Modulation of high-voltage-activated calcium channels in rat CNS neurons

      CALCIUM ION MODULATORS
    75. Uneyama, H; Uchida, H; Maeda, K; Yoshimoto, R; Watanabe, Y; Inoue, K
      Non-L-type actions of organic Ca2+ channel blockers: Implications for Na+ and N-type Ca2+ channels blockades

      CALCIUM ION MODULATORS
    76. WILDE AAM; DUREN DR; HAUER RNW; DEBAKKER JMT; BAKKER PFA; BECKER AE; JANSE MJ
      MITRAL-VALVE PROLAPSE AND VENTRICULAR ARRHYTHMIAS - OBSERVATIONS IN APATIENT WITH A 20-YEAR HISTORY

      Journal of cardiovascular electrophysiology
    77. BLACKBURNMUNRO G; FLEETWOODWALKER SM
      THE EFFECTS OF NA+ CHANNEL BLOCKERS ON SOMATOSENSORY PROCESSING BY RAT DORSAL HORN NEURONS

      NeuroReport
    78. ISHIBASHI H; RHEE JS; AKAIKE N
      EFFECT OF NILVADIPINE ON HIGH-VOLTAGE ACTIVATED CA2+ CHANNELS IN RAT CNS NEURONS

      NeuroReport
    79. DEBOCK GH; EELHART J; VANMARWIJK HWJ; TROMP TP; SPRINGER MP
      A POSTMARKETING STUDY OF FLUNARIZINE IN MIGRAINE AND VERTIGO

      Pharmacy world & science
    80. MELCON MO; ANDERSON DW; VERGARA RH; ROCCA WA
      PREVALENCE OF PARKINSONS-DISEASE IN JUNIN, BUENOS-AIRES PROVINCE, ARGENTINA

      Movement disorders
    81. NEGROTTI A; CALZETTI S
      A LONG-TERM FOLLOW-UP-STUDY OF CINNARIZINE-INDUCED AND FLUNARIZINE-INDUCED PARKINSONISM

      Movement disorders
    82. CUPINI LM; CALABRESI P; SILVESTRINI M; TROISI E; MATTEIS M; ARGIRO G; BERNARDI G
      PROLACTIN RESPONSE TO BROMOCRIPTINE IN FLUNARIZINE-TREATED MIGRAINOUSWOMEN

      Clinical neuropharmacology
    83. ZUMKELLER M; HEISSLER HE; DIETZ H
      ON THE EFFECT OF CALCIUM-ANTAGONISTS ON CEREBRAL BLOOD-FLOW IN RATS -A COMPARISON OF NIMODIPINE AND FLUNARIZINE

      Neurosurgical review
    84. FROSCHER W; WELTER M
      CHOREIFORM HYPERKINESIAS IN 2 PATIENTS WI TH EPILEPSY, INDUCED BY DISCONTINUING PHENOBARBITAL

      Aktuelle Neurologie
    85. WOOD NI; BARONE FC; BENHAM CD; BROWN TH; CAMPBELL CA; COOPER DG; EVANS ML; FEUERSTEIN GZ; HAMILTON TC; HARRIES MH; KING PD; MEAKIN JE; MURKITT KL; PATEL SR; PRICE WJ; ROBERTS JC; ROTHAUL AL; SAMSON NA; SMITH SJ; HUNTER AJ
      THE EFFECTS OF SB 206284A, A NOVEL NEURONAL CALCIUM-CHANNEL ANTAGONIST, IN MODELS OF CEREBRAL-ISCHEMIA

      Journal of cerebral blood flow and metabolism
    86. MAHMOOD I; SAHLROOT JT
      A LIMITED SAMPLING METHOD FOR THE ESTIMATION OF FLUNARIZINE AREA-UNDER-THE-CURVE (AUC) AND MAXIMUM PLASMA-CONCENTRATION (C-MAX)

      Biopharmaceutics & drug disposition
    87. GENKOVAPAPAZOVA M; PETKOVA BP; LAZAROVABAKAROVA M; BOYANOVA E; STANEVASTOYTCHEVA D
      EFFECTS OF FLUNARIZINE AND NITRENDIPINE ON ELECTROCONVULSIVE SHOCK-INDUCED AND CLONIDINE-INDUCED AMNESIA

      Pharmacology, biochemistry and behavior
    88. HARAGUCHI K; ITO K; KOTAKI H; SAWADA Y; IGA T
      PREDICTION OF DRUG-INDUCED CATALEPSY BASED ON DOPAMINE D-1, D-2, AND MUSCARINIC ACETYLCHOLINE-RECEPTOR OCCUPANCIES

      Drug metabolism and disposition
    89. WEIZMAN R; PANKOVA IA; SCHREIBER S; PICK CG
      FLUNARIZINE ANALGESIA IS MEDIATED BY MU-OPIOID RECEPTORS

      Physiology & behavior
    90. PEROUTKA SJ
      DOPAMINE AND MIGRAINE

      Neurology
    91. PEROUTKA SJ; WILHOIT T; JONES K
      CLINICAL-SUSCEPTIBILITY TO MIGRAINE WITH AURA IS MODIFIED BY DOPAMINED-2 RECEPTOR (DRD2) NCOI ALLELES

      Neurology
    92. ROTHROCK JF
      PHARMACOLOGICAL PROPHYLAXIS OF MIGRAINE

      Medicamentos de actualidad
    93. NOA M; MAS R; MESA R
      EFFECT OF POLICOSANOL ON CIRCULATING ENDOTHELIAL-CELLS IN EXPERIMENTAL-MODELS IN SPRAGUE-DAWLEY RATS AND IN RABBITS

      Journal of Pharmacy and Pharmacology
    94. ROSNER M; SOLBERG Y; TURETZ J; BELKIN M
      NEUROPROTECTIVE THERAPY FOR ARGON-LASER INDUCED RETINAL INJURY

      Experimental Eye Research
    95. MONTIEL C; HERRERO CJ; GARCIAPALOMERO E; RENART J; GARCIA AG; LOMAX RB
      SEROTONERGIC EFFECTS OF DOTARIZINE IN CORONARY-ARTERY AND IN OOCYTES EXPRESSING 5-HT2 RECEPTORS

      European journal of pharmacology
    96. AYAJIKI K; OKAMURA T; TODA N
      FLUNARIZINE, AN ANTIMIGRAINE AGENT, IMPAIRS NITROXIDERGIC NERVE FUNCTION IN CEREBRAL-ARTERIES

      European journal of pharmacology
    97. LARA B; GANDIA L; TORRES A; OLIVARES R; MARTINEZSIERRA R; GARCIA AG; LOPEZ MG
      WIDE-SPECTRUM CA2- LIPOPHILICITY, INHIBITION, AND RECOVERY OF SECRETION IN CHROMAFFIN CELLS( CHANNEL ANTAGONISTS )

      European journal of pharmacology
    98. BOROWICZ KK; GASIOR M; KLEINROK Z; CZUCZWAR SJ
      INFLUENCE OF ISRADIPINE, NIGULDIPINE AND DANTROLENE ON THE ANTICONVULSIVE ACTION OF CONVENTIONAL ANTIEPILEPTICS IN MICE

      European journal of pharmacology
    99. EDMEADS JG; GAWEL MJ; VICKERS J
      STRATEGIES FOR DIAGNOSING AND MANAGING MEDICATION-INDUCED HEADACHE

      Canadian family physician
    100. MARGINEANU DG; WULFERT E
      INHIBITION BY LEVETIRACETAM OF A NON-GABA(A) RECEPTOR-ASSOCIATED EPILEPTIFORM EFFECT OF BICUCULLINE IN RAT HIPPOCAMPUS

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/19 alle ore 13:18:54